Investigation of the maternal and cord plasma levels of IL-1 beta, TNF-alpha and VEGF in early membrane rupture

dc.contributor.authorKucukgul, Sukran
dc.contributor.authorOzkan, Zehra Sema
dc.contributor.authorYavuzkir, Seyda
dc.contributor.authorIlhan, Necip
dc.date.accessioned2026-08-12T17:16:41Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: Recent studies indicate a relationship between early membrane rupture (EMR) and proinflammatory cytokines like tumor necrosis factor (TNF) and interleukin (IL) and angiogenic factors like vascular endothelial growth factor (VEGF). In this study, we aimed to investigate the relationship between EMR and maternal and cord blood plasma levels of TNF-alpha, IL-1 beta and VEGF. Methods: This prospective, cross-sectional study was conducted with 85 pregnant women. The patients were divided into four groups as Group I (term EMR group, n = 21), Group II (preterm EMR group, n = 23), Group III (preterm non-EMR group, n = 19) and Group IV (term non-EMR group, n = 22). Plasma levels were assayed with ELISA method. Results: IL-1 beta levels were significantly lower, but TNF-alpha levels were significantly higher in maternal and cord plasma of EMR participants compared to non-EMR participants. There was no significant difference for VEGF levels. Cord plasma TNF-alpha levels were significantly higher than maternal plasma levels in EMR participants and cord plasma. VEGF levels were significantly higher than maternal levels in all participants. Conclusions: Higher TNF-alpha levels in our EMR participants indicate an inflammatory process during EMR. Higher cord plasma VEGF levels may point out placental or fetal production. Further studies conducted with expanded populations are needed to discuss our results.
dc.description.sponsorshipFirat University Scientific Research Foundation
dc.description.sponsorshipThis study was supported by Firat University Scientific Research Foundation. All authors declare that they have no conflict of interest.
dc.identifier.doi10.3109/14767058.2015.1077511
dc.identifier.endpage2160
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue13
dc.identifier.orcid0000-0001-9997-0418
dc.identifier.orcid0000-0001-9185-3663
dc.identifier.pmid26364900
dc.identifier.scopus2-s2.0-84941253472
dc.identifier.scopusqualityQ1
dc.identifier.startpage2157
dc.identifier.urihttps://doi.org/10.3109/14767058.2015.1077511
dc.identifier.urihttps://hdl.handle.net/11508/52366
dc.identifier.volume29
dc.identifier.wosWOS:000374773800022
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Maternal-Fetal & Neonatal Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectDelivery
dc.subjectearly membrane rupture
dc.subjectinterleukin 1 beta
dc.subjecttumor necrosis factor alpha
dc.subjectvascular endothelial growth factor
dc.titleInvestigation of the maternal and cord plasma levels of IL-1 beta, TNF-alpha and VEGF in early membrane rupture
dc.typeArticle

Dosyalar